Investor Long Focus Capital Management, Llc
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Long Focus Capital Management, Llc . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-08-14 13G AZULQ / Azul S.A. - Depositary Receipt (Common Stock) 5,632,943 0
2025-08-14 13G CTRN / Citi Trends, Inc. 556,455 440,000
2025-05-15 13G/A SGHT / Sight Sciences, Inc. 2,559,003 3,126,508
2025-05-15 13G/A 0
2025-05-15 13G/A HLF / Herbalife Ltd. 5,051,000 4,943,000
2025-05-15 13G/A 380,330
2025-05-15 13G/A AURA / Aura Biosciences, Inc. 2,507,774 3,319,582
2025-04-22 13G FIP / FTAI Infrastructure Inc. 5,701,162
2025-02-11 13G/A CLLS / Cellectis S.A. - Depositary Receipt (Common Stock) 4,487,293 4,617,293
2025-02-11 13G/A VINC / Vincerx Pharma, Inc. 1,098,753 0
2025-02-11 13G/A CTRN / Citi Trends, Inc. 435,673 556,455
2025-02-11 13G/A TLYS / Tilly's, Inc. 1,831,931 2,181,931
2025-02-11 13G/A ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) 12,086,915 20,494,393
2025-02-11 13G/A OPRT / Oportun Financial Corporation 1,740,777 1,740,777
2025-02-05 13G HLF / Herbalife Ltd. 5,051,000
2025-01-23 13G SGHT / Sight Sciences, Inc. 2,559,003
2025-01-03 13G AURA / Aura Biosciences, Inc. 2,507,774
2025-01-03 13G/A AURA / Aura Biosciences, Inc. 2,507,774
2024-12-06 13G AZULQ / Azul S.A. - Depositary Receipt (Common Stock) 5,632,943
2024-08-07 13G CTRN / Citi Trends, Inc. 435,673
2024-04-17 13G OPRT / Oportun Financial Corporation 1,740,777
2024-03-01 13G/A HYZN / Hyzon Motors Inc. 13,250,700 19,617,244
2024-02-14 13G/A TLYS / Tilly's, Inc. 1,699,379 1,831,931
2024-02-14 13G/A VINC / Vincerx Pharma, Inc. 1,414,951 1,098,753
2024-02-14 13G/A ONIT / Onity Group Inc. 652,088 652,088
2024-02-14 13G/A QMCO / Quantum Corporation 9,160,819
2024-02-14 13G/A CUROQ / CURO Group Holdings Corp. 2,999,524 3,396,130
2024-02-14 13G/A HYZN / Hyzon Motors Inc. 13,022,055 13,250,700
2024-02-14 13G/A CLLS / Cellectis S.A. - Depositary Receipt (Common Stock) 2,683,633 4,487,293
2024-02-14 13G/A ASPU / Aspen Group, Inc. 2,713,592 2,713,592
2024-02-14 13G/A ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) 11,312,347 12,086,915
2023-11-08 13G ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) 11,312,347
2023-06-09 13G CUROQ / CURO Group Holdings Corp. 2,999,524
2023-05-25 13G HYZN / Hyzon Motors Inc. 13,022,055
2023-05-11 13G TLYS / Tilly's, Inc. 1,699,379
2023-05-11 13G QMCO / Quantum Corporation 5,285,499
2023-02-14 13G/A ONIT / Onity Group Inc. 461,666 652,088
2023-02-14 13G/A CLLS / Cellectis S.A. - Depositary Receipt (Common Stock) 2,542,359 2,683,633
2023-02-14 13G/A ASPU / Aspen Group, Inc. 1,501,163 2,713,592
2023-02-14 13G VINC / Vincerx Pharma, Inc. 1,414,951
2022-05-20 13G ASPU / Aspen Group, Inc. 1,501,163
2022-05-03 13G CLLS / Cellectis S.A. - Depositary Receipt (Common Stock) 2,542,359
2022-04-29 13G OCN / Ocwen Financial Corporation 461,666
2019-02-13 13G/A CASM / CAS Medical Systems, Inc. 2,150,000 471,116
2018-02-14 13G/A CASM / CAS Medical Systems, Inc. 1,940,997 2,150,000
2017-12-01 13G CASM / CAS Medical Systems, Inc. 1,940,997
2014-04-24 13G/A CEI / Camber Energy, Inc. 4,344,834
2014-03-14 13G CEI / Camber Energy, Inc. 2,678,168